Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease.
Adi Nitzan-LuquesMordechai SlaeDiaa ZugayarBradley P DixonKaren MeirOded VolovelskyPublished in: Journal of nephrology (2020)
Neonatal thrombotic microangiopathy (TMA) is a rare and severe disease characterized by a triad of non-immune hemolytic anemia, thrombocytopenia, and organ dysfunction in neonates. We describe herein an early-term infant who underwent hemicolectomy at 4 days of age due to intestinal perforation. Following surgery, the patient had recurrent bouts of vomiting and abdominal distention, together with acute kidney injury, non-immune hemolytic anemia, and severe thrombocytopenia. Low complement levels raised the possibility of complement-mediated neonatal TMA. Finally, genetic tests identified a heterozygous mutation in the complement factor I gene. Anti-C5 monoclonal antibody therapy led to complete cessation of the hematological and renal manifestations, but symptoms of intestinal obstruction recurred. Intestinal biopsy demonstrated aganglionosis, compatible with Hirschsprung disease. This presentation is the first known case of neonatal complement-mediated TMA associated with Hirschsprung disease. Moreover, it highlights the importance of considering a diagnosis of TMA in cases of atypical neonatal infectious presentation.
Keyphrases
- acute kidney injury
- monoclonal antibody
- early onset
- chronic kidney disease
- case report
- genome wide
- oxidative stress
- minimally invasive
- copy number
- physical activity
- coronary artery bypass
- transcription factor
- sleep quality
- mesenchymal stem cells
- depressive symptoms
- drug induced
- coronary artery disease
- gestational age